디지털 심리요법 시장 예측(-2030년) : 유형별, 솔루션별, 비지니스 모델별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Digital Psychotherapeutics Market is accounted for $1.06 billion in 2023 and is expected to reach $10.25 billion by 2030 growing at a CAGR of 27.6% during the forecast period. Digital psychotherapeutics refers to the use of digital technologies, such as mobile apps and online platforms, to deliver therapeutic interventions for mental health issues. These solutions often incorporate evidence-based therapeutic techniques, such cognitive-behavioural therapy (CBT) or mindfulness, and can provide remote and accessible support to individuals seeking mental health care.

According to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16-85 years). In addition, 1 out of every 8 individuals in this world suffers from a psychological disorder.

Market Dynamics:

Driver:

Increasing mental health disorders

The heightened societal stressors, economic uncertainties and the impact of the digital age surge in mental health disorders. Also, modern lifestyles, with high-pressure work environments and constant connectivity, may exacerbate mental health challenges, leading to a notable increase in the prevalence of mental health disorders. Digital psychotherapeutics leverage technology to offer scalable, personalized interventions, making mental health support more widely available. This surge in demand is driving the expansion of the market, as individuals and healthcare providers increasingly turn to digital solutions to address the escalating challenges associated with mental health disorders.

Restraint:

Data privacy & security concerns

The sensitive nature of mental health data makes it a prime target for cyber threats, potentially leading to unauthorized access and misuse. Patients may hesitate to adopt digital psychotherapeutic solutions due to fears of breaches in confidentiality. Building robust encryption and authentication mechanisms is crucial to instill trust among users, but the persistent threat of data breaches remains a key challenge, impeding the widespread adoption of digital psychotherapeutics.

Opportunity:

Rising user-friendly platforms & apps

The user-friendly platforms and apps leverage user-centric design and advanced technologies to enhance accessibility and engagement in mental health interventions. With a focus on convenience and personalized experiences, these rising platforms cater to a broader audience, fostering increased adoption of digital psychotherapeutics. As the demand for accessible mental health solutions continues to rise, the market is poised for expansion through these user-friendly applications.

Threat:

Competition with traditional therapies

While the convenience and accessibility of digital solutions offer advantages, some individuals and healthcare providers may still prefer or rely on traditional therapeutic approaches. Skepticism around the efficacy and reliability of digital psychotherapeutics may impede their acceptance. Trust in well-known methods and the personalized nature of traditional therapy contributes to the competitive landscape. Therefore, the established reputation and long-standing acceptance of traditional therapeutic methods pose a significant challenge for the market to gain traction.

Covid-19 Impact

The covid-19 pandemic has significantly accelerated the adoption of Digital Psychotherapeutics, witnessing a surge in demand as mental health challenges escalated globally. The increased awareness of mental well-being, coupled with lockdowns and social distancing measures, prompted a shift towards remote and digital mental health solutions. Teletherapy platforms, mental health apps, and virtual support tools experienced heightened acceptance, driving the digital psychotherapeutics market.

The wearable devices segment is expected to be the largest during the forecast period

The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in digital psychotherapeutics by integrating technology into mental health interventions. These devices, often worn on the body, collect real-time physiological data, enabling personalized and data-driven therapy. They enhance therapy effectiveness by monitoring vital signs, sleep patterns, and activity levels, providing therapists with objective insights. This continuous data stream fosters more targeted interventions and allows for timely adjustments to treatment plans.

The anxiety disorders segment is expected to have the highest CAGR during the forecast period

The anxiety disorders segment is anticipated to witness the highest CAGR growth during the forecast period. Digital psychotherapeutics offer promising solutions for anxiety disorders by providing accessible, personalized, and scalable interventions. These platforms often incorporate evidence-based therapeutic techniques, cognitive-behavioural therapy modules, and mindfulness practices to address anxiety symptoms. It's convenient and flexible approach to mental health care fuels the segment demand.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing awareness of mental health issues, rising smartphone penetration, and advancements in technology. The covid-19 pandemic's impact on mental health raised the acceptance of telehealth in the region. China is well-known for its strong technology infrastructure and telemedicine, mobile health applications, & wearable gadgets have seen tremendous improvements in the country. Thereby, robust advancements in telemedicine and digital health technology is likely to continue pushing growth in the region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period owing to the favourable reimbursement scenarios. The digital psychotherapeutics industry in the United States is expected to progress as the country's mental health awareness grows. Anxiety, depression, and post-traumatic stress disorder (PTSD) are common mental health illnesses in the United States. North America is a key player in shaping the future of digital psychotherapeutics, fostering innovation and accessibility. The region's well-established healthcare infrastructure, coupled with a growing acceptance of digital interventions, fosters market expansion.

Key players in the market

Some of the key players profiled in the Digital Psychotherapeutics Market include Pear Therapeutics, Akili Interactive, Happify Health, Headspace, Ginger, Lantern, Limbix, Big Health, Mindstrong Health, NeuroFlow, SilverCloud Health, Talkspace, Woebot Health, Kaia Health, Novartis, Spring Health, Koa Health and Meru Health.

Key Developments:

In November 2023, Spring Health, the most comprehensive global mental health solution for employers and health plans, announced the launch of a new dedicated teen experience. Spring Health for teens is the latest innovation in the Family Care suite of services, which offers mental health care and support for all ages.

In November 2018, Sandoz, a division of Novartis partnered with Pear Therapeutics and launched reSET - a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA. reSET is a 12-week digital cognitive behavioral therapy program accessed through an app and designed to accompany outpatient care delivered by a physician.

Types Covered:

• Cognitive Behavioural Therapy (CBT)
• Mindfulness-based Therapy
• Other Types

Solutions Covered:

• Mobile Applications
• Web-based Platforms
• Virtual Reality (VR) Solutions
• Wearable Devices
• Other Solutions

Business Models Covered:

• Direct-To-Patients/Consumers
• Business-To-Business (B2B)

Applications Covered:

• Anxiety Disorders
• Depression
• Substance Use Disorders
• Sleep Disorders
• Eating Disorders
• Other Applications

End Users Covered:

• Healthcare Providers
• Patients
• Employers
• Insurers

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Digital Psychotherapeutics Market, By Type

• 5.1 Introduction
• 5.2 Cognitive Behavioural Therapy (CBT)
• 5.3 Mindfulness-based Therapy
• 5.4 Other Types

6 Global Digital Psychotherapeutics Market, By Solution

• 6.1 Introduction
• 6.2 Mobile Applications
• 6.3 Web-based Platforms
• 6.4 Virtual Reality (VR) Solutions
• 6.5 Wearable Devices
• 6.6 Other Solutions

7 Global Digital Psychotherapeutics Market, By Business Model

• 7.1 Introduction
• 7.2 Direct-To-Patients/Consumers
• 7.3 Business-To-Business (B2B)

8 Global Digital Psychotherapeutics Market, By Application

• 8.1 Introduction
• 8.2 Anxiety Disorders
• 8.3 Depression
• 8.4 Substance Use Disorders
• 8.5 Sleep Disorders
• 8.6 Eating Disorders
• 8.7 Other Applications

9 Global Digital Psychotherapeutics Market, By End User

• 9.1 Introduction
• 9.2 Healthcare Providers
• 9.3 Patients
• 9.4 Employers
• 9.5 Insurers

10 Global Digital Psychotherapeutics Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Pear Therapeutics
• 12.2 Akili Interactive
• 12.3 Happify Health
• 12.4 Headspace
• 12.5 Ginger
• 12.6 Lantern
• 12.7 Limbix
• 12.8 Big Health
• 12.9 Mindstrong Health
• 12.10 NeuroFlow
• 12.11 SilverCloud Health
• 12.12 Talkspace
• 12.13 Woebot Health
• 12.14 Kaia Health
• 12.15 Novartis
• 12.16 Spring Health
• 12.17 Koa Health
• 12.18 Meru Health